Literature DB >> 21069446

Population- and family-based studies associate the MTHFR gene with idiopathic autism in simplex families.

Xudong Liu1, Fatima Solehdin, Ira L Cohen, Maripaz G Gonzalez, Edmund C Jenkins, M E Suzanne Lewis, Jeanette J A Holden.   

Abstract

Two methylenetetrahydrofolate reductase gene (MTHFR) functional polymorphisms were studied in 205 North American simplex (SPX) and 307 multiplex (MPX) families having one or more children with an autism spectrum disorder. Case-control comparisons revealed a significantly higher frequency of the low-activity 677T allele, higher prevalence of the 677TT genotype and higher frequencies of the 677T-1298A haplotype and double homozygous 677TT/1298AA genotype in affected individuals relative to controls. Family-based association testing demonstrated significant preferential transmission of the 677T and 1298A alleles and the 677T-1298A haplotype to affected offspring. The results were not replicated in MPX families. The results associate the MTHFR gene with autism in SPX families only, suggesting that reduced MTHFR activity is a risk factor for autism in these families.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21069446     DOI: 10.1007/s10803-010-1120-x

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  41 in total

Review 1.  Genomic imprinting: parental influence on the genome.

Authors:  W Reik; J Walter
Journal:  Nat Rev Genet       Date:  2001-01       Impact factor: 53.242

2.  Imprinted genes, cognition and behaviour.

Authors: 
Journal:  Trends Cogn Sci       Date:  2000-08       Impact factor: 20.229

Review 3.  Epigenetics of autism spectrum disorders.

Authors:  N Carolyn Schanen
Journal:  Hum Mol Genet       Date:  2006-10-15       Impact factor: 6.150

4.  The MTHFR 1298A>C polymorphism and genomic DNA methylation in human lymphocytes.

Authors:  Simonetta Friso; Domenico Girelli; Elisabetta Trabetti; Oliviero Olivieri; Patrizia Guarini; Pier Franco Pignatti; Roberto Corrocher; Sang-Woon Choi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

5.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  American Academy of Pediatrics: The pediatrician's role in the diagnosis and management of autistic spectrum disorder in children.

Authors: 
Journal:  Pediatrics       Date:  2001-05       Impact factor: 7.124

7.  Phenomic determinants of genomic variation in autism spectrum disorders.

Authors:  Y Qiao; N Riendeau; M Koochek; X Liu; Chansonette Harvard; M J Hildebrand; J J A Holden; E Rajcan-Separovic; M E S Lewis
Journal:  J Med Genet       Date:  2009-07-21       Impact factor: 6.318

8.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

9.  Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.

Authors:  Susan L Christian; Camille W Brune; Jyotsna Sudi; Ravinesh A Kumar; Shaung Liu; Samer Karamohamed; Judith A Badner; Seiichi Matsui; Jeffrey Conroy; Devin McQuaid; James Gergel; Eli Hatchwell; T Conrad Gilliam; Elliot S Gershon; Norma J Nowak; William B Dobyns; Edwin H Cook
Journal:  Biol Psychiatry       Date:  2008-03-28       Impact factor: 13.382

10.  Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.

Authors:  Elisabetta Tabolacci; Roberta Pietrobono; Umberto Moscato; Ben A Oostra; Pietro Chiurazzi; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2005-05       Impact factor: 4.246

View more
  20 in total

Review 1.  Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder.

Authors:  Geir Bjørklund; Nagwa A Meguid; Afaf El-Ansary; Mona A El-Bana; Maryam Dadar; Jan Aaseth; Maha Hemimi; Joško Osredkar; Salvatore Chirumbolo
Journal:  J Mol Neurosci       Date:  2018-10-24       Impact factor: 3.444

Review 2.  Association of methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism with autism: evidence of genetic susceptibility.

Authors:  Vandana Rai
Journal:  Metab Brain Dis       Date:  2016-03-08       Impact factor: 3.584

Review 3.  A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panel.

Authors:  Richard E Frye; Daniel Rossignol; Manuel F Casanova; Gregory L Brown; Victoria Martin; Stephen Edelson; Robert Coben; Jeffrey Lewine; John C Slattery; Chrystal Lau; Paul Hardy; S Hossein Fatemi; Timothy D Folsom; Derrick Macfabe; James B Adams
Journal:  Front Public Health       Date:  2013-09-13

4.  MTHFR Gene C677T Polymorphism in Autism Spectrum Disorders.

Authors:  Elif Funda Sener; Didem Behice Oztop; Yusuf Ozkul
Journal:  Genet Res Int       Date:  2014-11-06

5.  Helicobacter pylori moderates the association between 5-MTHF concentration and cognitive function in older adults.

Authors:  Andrew N Berrett; Shawn D Gale; Lance D Erickson; Bruce L Brown; Dawson W Hedges
Journal:  PLoS One       Date:  2018-01-24       Impact factor: 3.240

Review 6.  Genetics and Epigenetics of One-Carbon Metabolism Pathway in Autism Spectrum Disorder: A Sex-Specific Brain Epigenome?

Authors:  Veronica Tisato; Juliana A Silva; Giovanna Longo; Ines Gallo; Ajay V Singh; Daniela Milani; Donato Gemmati
Journal:  Genes (Basel)       Date:  2021-05-20       Impact factor: 4.096

Review 7.  Autism risk factors: genes, environment, and gene-environment interactions.

Authors:  Pauline Chaste; Marion Leboyer
Journal:  Dialogues Clin Neurosci       Date:  2012-09       Impact factor: 5.986

8.  Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala.

Authors:  George Anderson; Michael Maes
Journal:  Curr Neuropharmacol       Date:  2014-03       Impact factor: 7.363

Review 9.  Treatments for biomedical abnormalities associated with autism spectrum disorder.

Authors:  Richard Eugene Frye; Daniel A Rossignol
Journal:  Front Pediatr       Date:  2014-06-27       Impact factor: 3.418

Review 10.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.